SCHEMBL9944283

SCHEMBL9944283

Cc1cc(NC(=O)c2cc(Cl)c(OC(C)C)c(Cl)c2)ccc1C=O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAU P00749 3/20 0.47
TAS1R3 Q7RTX0 3/20 0.47
TAS1R1 Q7RTX1 3/20 0.47
TAS1R2 Q8TE23 3/20 0.47
RORC P51449 1/20 0.42
NPC1 O15118 5/20 0.42
RAB9A P51151 5/20 0.42
MAPT P10636 3/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
KDM4E B2RXH2 1/20 0.42
PKM P14618 1/20 0.42
HTT P42858 1/20 0.40
POLB P06746 1/20 0.40
CASP3 P42574 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
TP53 P04637 1/20 0.40
FKBP5 Q13451 1/20 0.40
NFKB1 P19838 1/20 0.39
NFKB2 Q00653 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9944282 0.90 MAPT (0.47) PLAUTAS1R3TAS1R1TAS1R2RORC
SCHEMBL9944353 0.89 TAS1R3 (0.50) PLAUTAS1R3TAS1R1TAS1R2RORC
SCHEMBL9944304 0.89 MAPT (0.50) PLAUNPC1RAB9AMAPTMEN1
SCHEMBL9944332 0.87 RORC (0.45) PLAUTAS1R3TAS1R1TAS1R2RORC
SCHEMBL9944331 0.86 RAB9A (0.49) PLAURORCNPC1RAB9AMAPT
SCHEMBL9944296 0.85 TAS1R3 (0.46) PLAUTAS1R3TAS1R1TAS1R2NPC1
SCHEMBL9944164 0.83 PLAU (0.49) PLAUTAS1R3TAS1R1TAS1R2RORC
SCHEMBL9944342 0.82 MAPT (0.49) NPC1RAB9AMAPTMEN1KMT2A
SCHEMBL9944076 0.82 RAB9A (0.50) PLAUTAS1R3TAS1R1TAS1R2RORC
SCHEMBL9944323 0.82 TAS1R3 (0.44) TAS1R3TAS1R1TAS1R2RORCNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120149737-A1 Therapeutic Aryl-Amido-Aryl Compounds and Their Use KING'S COLLEGE LONDON (GB) 2012-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120149737-A1 Therapeutic Aryl-Amido-Aryl Compounds and Their Use RARA, RARB, RARG PLAU 4014/4885TAS1R3 1123/4885TAS1R1 693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.